Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models
Epigenetic mechanisms play a role in human disease but their involvement in pathologies from the central nervous system has been hampered by the complexity of the brain together with its unique cellular architecture and diversity. Until recently, disease targeted neural types were only available as...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/9464591 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562296104157184 |
|---|---|
| author | Rubén Fernández-Santiago Mario Ezquerra |
| author_facet | Rubén Fernández-Santiago Mario Ezquerra |
| author_sort | Rubén Fernández-Santiago |
| collection | DOAJ |
| description | Epigenetic mechanisms play a role in human disease but their involvement in pathologies from the central nervous system has been hampered by the complexity of the brain together with its unique cellular architecture and diversity. Until recently, disease targeted neural types were only available as postmortem materials after many years of disease evolution. Current in vitro systems of induced pluripotent stem cells (iPSCs) generated by cell reprogramming of somatic cells from patients have provided valuable disease models recapitulating key pathological molecular events. Yet whether cell reprogramming on itself implies a truly epigenetic reprogramming, the epigenetic mechanisms governing this process are only partially understood. Moreover, elucidating epigenetic regulation using patient-specific iPSC-derived neural models is expected to have a great impact to unravel the pathophysiology of neurodegenerative diseases and to hopefully expand future therapeutic possibilities. Here we will critically review current knowledge of epigenetic involvement in neurodegenerative disorders focusing on the potential of iPSCs as a promising tool for epigenetic research of these diseases. |
| format | Article |
| id | doaj-art-e8fd0a7838de48a48f857551dd325404 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-e8fd0a7838de48a48f857551dd3254042025-02-03T01:23:06ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/94645919464591Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsRubén Fernández-Santiago0Mario Ezquerra1Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, Hospital Clinic of Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), 08036 Barcelona, SpainLaboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, Hospital Clinic of Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), 08036 Barcelona, SpainEpigenetic mechanisms play a role in human disease but their involvement in pathologies from the central nervous system has been hampered by the complexity of the brain together with its unique cellular architecture and diversity. Until recently, disease targeted neural types were only available as postmortem materials after many years of disease evolution. Current in vitro systems of induced pluripotent stem cells (iPSCs) generated by cell reprogramming of somatic cells from patients have provided valuable disease models recapitulating key pathological molecular events. Yet whether cell reprogramming on itself implies a truly epigenetic reprogramming, the epigenetic mechanisms governing this process are only partially understood. Moreover, elucidating epigenetic regulation using patient-specific iPSC-derived neural models is expected to have a great impact to unravel the pathophysiology of neurodegenerative diseases and to hopefully expand future therapeutic possibilities. Here we will critically review current knowledge of epigenetic involvement in neurodegenerative disorders focusing on the potential of iPSCs as a promising tool for epigenetic research of these diseases.http://dx.doi.org/10.1155/2016/9464591 |
| spellingShingle | Rubén Fernández-Santiago Mario Ezquerra Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models Stem Cells International |
| title | Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models |
| title_full | Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models |
| title_fullStr | Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models |
| title_full_unstemmed | Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models |
| title_short | Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models |
| title_sort | epigenetic research of neurodegenerative disorders using patient ipsc based models |
| url | http://dx.doi.org/10.1155/2016/9464591 |
| work_keys_str_mv | AT rubenfernandezsantiago epigeneticresearchofneurodegenerativedisordersusingpatientipscbasedmodels AT marioezquerra epigeneticresearchofneurodegenerativedisordersusingpatientipscbasedmodels |